Crossmark

Lactacystin: first-in-class proteasome inhibitor still excelling and an exemplar for future antibiotic research

Crossref DOI link: https://doi.org/10.1038/s41429-019-0141-8

Published Online: 2019-02-12

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ōmura, Satoshi

Crump, Andy
License Information

Text and Data Mining valid from 2019-02-12
More Information

Article History

Received: 13 October 2018

Revised: 12 December 2018

Accepted: 7 January 2019

First Online: 12 February 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.